This study helps to elucidate a relationship between FGF19 and its respective receptor FGFR4 in the promotion of hepatic stem cells as indicated by increased EpCAM within the carcinogenesis sequence of fatty liver to hepatocellular carcinoma in the specimens. The gene discussed is FGF19; the disease is hepatocellular carcinoma.